FDA Inspection 1155166 — Kite Pharma, Inc.
The FDA completed an inspection of Kite Pharma, Inc. on October 22, 2021 in El Segundo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 22, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- El Segundo, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1434 | 21 CFR 211.42(c)(10)(iv) | Environmental Monitoring System |
| 9096 | 21 CFR 600.80(c)(1)(ii) | Reporting Requirements - 15-day alert follow up |